Influence of Liposome Composition on Plasmid DNA Delivery to Eukaryotic Cells

AA Mikheev, EV Shmendel, GV Nazarov… - Russian Journal of …, 2021 - Springer
Gene therapy is a promising method for the treatment of various diseases by introducing
therapeutic nucleic acids, for the delivery of which cationic liposomes are widely used. This …

[HTML][HTML] A novel disulfide-containing polycationic amphiphile: 1, 28-di [(cholest-5-en-3β-yl) disulfanyl]-4, 25-dioxo-3, 8, 12, 17, 21, 26-hexaazaoctacosane …

PA Puchkov, EV Shmendel, VD Andreeva… - Molbank, 2018 - mdpi.com
The absence of highly effective delivery systems is a major challenge for gene therapy. Our
work was aimed at the development of novel cationic liposomes possessing high …

Chronic myelocytic leukemia (CML) patient-derived dendritic cells transfected with autologous total RNA induces CML-specific cytotoxicity

L Yu, T Hu, T Zou, Q Shi, G Chen - Indian Journal of Hematology and …, 2016 - Springer
The oncogenic bcr/abl1 fusion gene is a chronic myelogenous leukemia (CML)-specific
antigen which is absent in normal tissues. This makes bcr/abl1 a perfect target for …

Nanomaterials for pharmaceutical applications

S Singh, SB Tiwari, S Tyagi - Emerging Trends in Nanotechnology, 2021 - Springer
The field of medicine and pharmaceuticals has experienced revolutionary changes due to
the development of nanotechnology. Materials or their constructions with size less than 100 …

Investigating the Fate of MP1000-LPX In Vivo by Adding Serum to Transfection Medium

S He, S Xia, X Song, H Huang, X Wang… - Pharmaceutical …, 2020 - ingentaconnect.com
Background: Cationic liposomes (CLs) based messenger RNA (mRNA) vaccine has been a
promising approach for cancer treatment. However, rapid lung accumulation after intraveous …

Langmuir-Blodgett Monolayer Studies of Mixed Gemini Surfactant-Phospholipid Monolayers system for Gene Therapy Applications.

T Ahmed - 2015 - uwspace.uwaterloo.ca
Gene delivery relies upon the encapsulation of a gene of interest, which is then ideally
delivered to target cells. For gene therapy applications, viral vectors are the most efficient …

[HTML][HTML] Направленный транспорт лекарственных препаратов в липидоподобных наноконтейнерах и внеклеточных везикулах

АВ Соколов, НН Костин, ЛА Овчинникова… - Acta Naturae …, 2019 - cyberleninka.ru
Возможность адресной доставки препаратов к определенным органам-мишеням,
тканям и клеткам открыла невероятные перспективы для разработки новых способов …

[PDF][PDF] Combined effects of oncolytic vaccinia virus and dendritic cells on the progression of melanoma B16-F10 in mice

EP Goncharova, TA Gamburg, OV Markov… - Journal of Cancer …, 2022 - academia.edu
Aim: We aimed to test the hypothesis that loading of dendritic cells (DCs) with both viral and
tumor-specific antigens would enhance the efficacy antitumor DC-based therapy applied …

[引用][C] 基于树突状细胞的肿瘤疫苗研究进展

吉海杰, 王黎明, 刘洋, 史高娜, 李会, 刘大庆, 李娜… - 中华细胞与干细胞杂志: 电子 …, 2013

Converging chemical-and cell-based approaches for improved non-viral gene delivery

F Ponti - 2022 - politesi.polimi.it
Non-viral gene delivery strategies have attracted significant interest in the development of
novel therapeutic approaches as well as for basic and applied research in vitro. Compared …